These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37377118)

  • 1. Mechanism of mycobacterial ATP synthase inhibition by squaramides and second generation diarylquinolines.
    Courbon GM; Palme PR; Mann L; Richter A; Imming P; Rubinstein JL
    EMBO J; 2023 Aug; 42(15):e113687. PubMed ID: 37377118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tale of two inhibitors: diarylquinolines and squaramides.
    Chen J; Ekiert DC
    EMBO J; 2023 Aug; 42(15):e114912. PubMed ID: 37435707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TBAJ-876 Retains Bedaquiline's Activity against Subunits c and ε of
    Sarathy JP; Ragunathan P; Shin J; Cooper CB; Upton AM; Grüber G; Dick T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of M. tuberculosis and human ATP synthase by BDQ and TBAJ-587.
    Zhang Y; Lai Y; Zhou S; Ran T; Zhang Y; Zhao Z; Feng Z; Yu L; Xu J; Shi K; Wang J; Pang Y; Li L; Chen H; Guddat LW; Gao Y; Liu F; Rao Z; Gong H
    Nature; 2024 Jul; 631(8020):409-414. PubMed ID: 38961288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TBAJ-876 Displays Bedaquiline-Like Mycobactericidal Potency without Retaining the Parental Drug's Uncoupler Activity.
    Sarathy JP; Ragunathan P; Cooper CB; Upton AM; Grüber G; Dick T
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase.
    Haagsma AC; Podasca I; Koul A; Andries K; Guillemont J; Lill H; Bald D
    PLoS One; 2011; 6(8):e23575. PubMed ID: 21858172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halting ionic shuttle to disrupt the synthetic machinery-Structural and molecular insights into the inhibitory roles of Bedaquiline towards Mycobacterium tuberculosis ATP synthase in the treatment of tuberculosis.
    Salifu EY; Agoni C; Olotu FA; Dokurugu YM; Soliman MES
    J Cell Biochem; 2019 Sep; 120(9):16108-16119. PubMed ID: 31125144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives.
    Salifu EY; Agoni C; Olotu FA; Soliman MES
    Comput Biol Chem; 2020 Apr; 85():107204. PubMed ID: 31981966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of mycobacterial ATP synthase bound to the tuberculosis drug bedaquiline.
    Guo H; Courbon GM; Bueler SA; Mai J; Liu J; Rubinstein JL
    Nature; 2021 Jan; 589(7840):143-147. PubMed ID: 33299175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding properties of the anti-TB drugs bedaquiline and TBAJ-876 to a mycobacterial F-ATP synthase.
    Krah A; Grüber G; Bond PJ
    Curr Res Struct Biol; 2022; 4():278-284. PubMed ID: 36186842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Efficacy of the Novel Diarylquinoline TBAJ-876 and Bedaquiline against a Resistant
    Almeida D; Converse PJ; Li SY; Upton AM; Fotouhi N; Nuermberger EL
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0141221. PubMed ID: 34570644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations of the Mycobacterium abscessus F-ATP synthase subunit a-c interface alter binding and potency of the anti-TB drug bedaquiline.
    Krah A; Ragunathan P; Bond PJ; Grüber G
    Biochem Biophys Res Commun; 2024 Jan; 690():149249. PubMed ID: 38000294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant
    Xu J; Converse PJ; Upton AM; Mdluli K; Fotouhi N; Nuermberger EL
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33526488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique structural and mechanistic properties of mycobacterial F-ATP synthases: Implications for drug design.
    Kamariah N; Ragunathan P; Shin J; Saw WG; Wong CF; Dick T; Grüber G
    Prog Biophys Mol Biol; 2020 May; 152():64-73. PubMed ID: 31743686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Perspective of ATP Synthase Inhibitors in the Management of the Tuberculosis.
    Divita KM; Khatik GL
    Curr Top Med Chem; 2021; 21(18):1623-1643. PubMed ID: 34517802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mutations in the mycobacterial ATP synthase: new insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure.
    Segala E; Sougakoff W; Nevejans-Chauffour A; Jarlier V; Petrella S
    Antimicrob Agents Chemother; 2012 May; 56(5):2326-34. PubMed ID: 22354303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP Synthase, an Emerging Target in TB Drug Discovery: Review of SAR and Clinical Pharmacology of Diarylquinoline Inhibitors.
    Dhulap A; Banerjee P
    Curr Drug Targets; 2021; 22(11):1207-1221. PubMed ID: 33480344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionophoric effects of the antitubercular drug bedaquiline.
    Hards K; McMillan DGG; Schurig-Briccio LA; Gennis RB; Lill H; Bald D; Cook GM
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7326-7331. PubMed ID: 29941569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
    Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-Understanding the Mechanisms of Action of the Anti-Mycobacterial Drug Bedaquiline.
    Sarathy JP; Gruber G; Dick T
    Antibiotics (Basel); 2019 Dec; 8(4):. PubMed ID: 31835707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.